364 related articles for article (PubMed ID: 19485898)
1. Targeting platelet G-protein coupled receptors (GPCRs): looking beyond conventional GPCR antagonism.
Dowal L; Flaumenhaft R
Curr Vasc Pharmacol; 2010 Mar; 8(2):140-54. PubMed ID: 19485898
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
Gurbel PA; Kuliopulos A; Tantry US
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
[TBL] [Abstract][Full Text] [Related]
4. Rare platelet GPCR variants: what can we learn?
Nisar SP; Jones ML; Cunningham MR; Mumford AD; Mundell SJ;
Br J Pharmacol; 2015 Jul; 172(13):3242-53. PubMed ID: 25231155
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling for the identification of G-protein coupled receptors in human platelets.
Amisten S; Braun OO; Bengtsson A; Erlinge D
Thromb Res; 2008; 122(1):47-57. PubMed ID: 17920662
[TBL] [Abstract][Full Text] [Related]
6. Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic.
Xiang Q; Pang X; Liu Z; Yang G; Tao W; Pei Q; Cui Y
Pharmacol Ther; 2019 Nov; 203():107393. PubMed ID: 31356909
[TBL] [Abstract][Full Text] [Related]
7. The Roles of GRKs in Hemostasis and Thrombosis.
Chen X; Zhao X; Cooper M; Ma P
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731360
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
[TBL] [Abstract][Full Text] [Related]
9. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
Eglen RM; Bosse R; Reisine T
Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
[TBL] [Abstract][Full Text] [Related]
10. The neurokinin 1 receptor: a potential new target for anti-platelet therapy?
Jones S; Gibbins JM
Curr Opin Pharmacol; 2008 Apr; 8(2):114-9. PubMed ID: 18296119
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological consequences of receptor mistraffic: Tales from the platelet P2Y
Cunningham MR; Aungraheeta R; Mundell SJ
Mol Cell Endocrinol; 2017 Jul; 449():74-81. PubMed ID: 28212842
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.
Iyú D; Glenn JR; White AE; Fox SC; van Giezen H; Nylander S; Heptinstall S
Thromb Haemost; 2011 Jan; 105(1):96-106. PubMed ID: 20941457
[TBL] [Abstract][Full Text] [Related]
13. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
Dunn HA; Orlandi C; Martemyanov KA
Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
[TBL] [Abstract][Full Text] [Related]
14. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
Covic L; Misra M; Badar J; Singh C; Kuliopulos A
Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.
Vallés J; Moscardo A; Madrid I; Santos MT
Curr Vasc Pharmacol; 2013 Jul; 11(4):431-47. PubMed ID: 23905638
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of platelet activation and development of antiplatelet agents].
Cazenave JP; Gachet C; Lanza F
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
18. New perspectives in antiplatelet therapy.
Tello-Montoliu A; Jover E; Rivera J; Valdés M; Angiolillo DJ; Marín F
Curr Med Chem; 2012; 19(3):406-27. PubMed ID: 22335515
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapies for the treatment of cardiovascular disease.
Michelson AD
Nat Rev Drug Discov; 2010 Feb; 9(2):154-69. PubMed ID: 20118963
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting.
Ting HJ; Murad JP; Espinosa EV; Khasawneh FT
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):248-59. PubMed ID: 22064668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
